ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,357, issued on May 12, was assigned to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea).

"Methods and compositions to promoting retinal regeneration using prox1 migration inhibitor as active ingredient" was invented by Jin Woo Kim (Daejeon, South Korea) and Eun Jung Lee (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a technique capable of treating a retinal neurodegenerative disease through regeneration of a retinal nerve by targeting Prox1 in the mammalian retina using an inhibitor which inhibits Prox1 expression or migration. According to the present invention, inducing...